Microbial production of glycolate from acetate by metabolically engineered Escherichia coli

•E. coli was engineered to produce glycolate from acetate.•Overexpression of pta-ackA significantly improved glycolate production.•Glycolate was accumulated up to 2.75 g/L in shake flask cultures. Escherichia coli was metabolically engineered to synthesize glycolate using acetate as the carbon sourc...

Full description

Saved in:
Bibliographic Details
Published inJournal of biotechnology Vol. 291; pp. 41 - 45
Main Authors Li, Wei, Chen, Jing, Liu, Chang-Xia, Yuan, Qi-Peng, Li, Zheng-Jun
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 10.02.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•E. coli was engineered to produce glycolate from acetate.•Overexpression of pta-ackA significantly improved glycolate production.•Glycolate was accumulated up to 2.75 g/L in shake flask cultures. Escherichia coli was metabolically engineered to synthesize glycolate using acetate as the carbon source. The native glyoxylate bypass pathway was reinforced by the overexpression of isocitrate lyase and isocitrate dehydrogenase kinase/phosphatase. Glyoxylate/hydroxypyruvate reductase was overexpressed to convert glyoxylate to glycolate. Meanwhile, side reactions were eliminated by inactivating genes encoding malate synthase, glyoxylate carboligase, and glycolate oxidase to prevent loss of glyoxylate and glycolate. The engineered E. coli produced 1.78 g/L glycolate from 3.23 g/L acetate after 48 h shake flask cultivation using minimal medium supplemented with 1 g/L yeast extract. When citrate synthase, phosphotransacetylase, and acetate kinase were co-overexpressed to strengthen the tricarboxylic acid cycle and acetate utilization, glycolate production titer was improved to 2.75 g/L with pH control in shake flasks. The results of this work offer an approach for producing glycolate using acetate as the carbon source.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0168-1656
1873-4863
DOI:10.1016/j.jbiotec.2018.12.012